Commure
Commure raises $220M Series B at $3.3B valuation
Quick Facts
Commure: Series B Funding Round
Commure has successfully raised $220M in Series B funding, reaching a valuation of $3.3B.
Company Overview
Healthcare software platform
Funding Details
The Series B round was led by General Catalyst, with participation from Founders Fund, 8VC, Human Capital, Definition Capital.
Company Information
- Headquarters: 650 California Street, San Francisco, CA 94108
- Founded: 2017
- Employees: 500+
- Category: HealthTech
Investment
Commure plans to use the funds to accelerate product development, expand its team, and scale operations globally.
About the Investors
- General Catalyst: Verified investor in Series B
- Founders Fund: Verified investor in Series B
- 8VC: Verified investor in Series B
- Human Capital: Verified investor in Series B
- Definition Capital: Verified investor in Series B
Key Investors
About the Author
Related Company Reports
Abridge Raises $150M Series C to Transform HealthTech
Abridge has secured $150M Series C in funding to accelerate growth and innovation in the healthtech sector. Medical AI scribe platform automatically documenting patient-provider conversations and generating clinical notes...
Innovaccer Raises $275M Series F to Transform HealthTech
Innovaccer has secured $275M Series F in funding to accelerate growth and innovation in the healthtech sector. Healthcare data platform unifying patient data and providing analytics for value-based care and population health manage...
Truveta Raises $95M Series B to Transform HealthTech
Truveta has secured $95M Series B in funding to accelerate growth and innovation in the healthtech sector. Healthcare data platform aggregating de-identified patient records to accelerate medical research and drug development...
